HCA Holdings (NYSE: HCA) reported Q2 EPS of $3.23, $3.74 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $11.07 billion versus the consensus estimate of $9.91 billion.

Key second quarter metrics (all percentage changes compare 2Q 2020 to 2Q 2019 unless otherwise noted):

• Revenues totaled $11.068 billion
• Net income attributable to HCA Healthcare, Inc. totaled $1.079 billion, or $3.16 per diluted share
• Adjusted EBITDA totaled $2.666 billion
• Cash flows from operating activities totaled $8.723 billion
• Same facility admissions declined 12.8 percent and same facility equivalent admissions declined 20.1 percent

“Throughout this remarkably challenging pandemic, I am reminded daily of what an incredible and resilient organization we have,” said Sam Hazen, Chief Executive Officer of HCA Healthcare. “I see our colleagues and physicians working every day to do the right thing for others, and I want to thank them for their dedication to our patients and the tremendous sacrifices they, and their families, are making in the midst of this global health crisis.”

“With our continued focus on our patients and the well-being of our colleagues and physicians, we can be proud of our accomplishments. I am confident that we are well positioned for long-term success and to continue the remarkable legacy that is HCA Healthcare,” stated Hazen.

For earnings history and earnings-related data on HCA Holdings (HCA) click here.